» Articles » PMID: 21125533

[The Intracranial Meningioma - Therapeutic Possibilities and Limitations]

Overview
Specialty General Medicine
Date 2010 Dec 3
PMID 21125533
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Meningiomas are common intracranial tumours that arise from arachnoidal cells. Clinically they often manifest by headache, focal or generalized seizures, or neurologic deficits as a result of brain compression. More than 90 percent of these mostly slow growing meningiomas are benign. In symptomatic patients a resection should be performed with the intention to cure or at least alleviate symptoms. In cases of subtotal resection an adjuvant radiotherapy should be deliberated. Stereotactic radiotherapy as initial treatment is an effective alternative for meningiomas, especially in patients not suitable for surgery due to various reasons. In patients that are refractory to treatment or with unresectable disease a hormonal- or chemotherapy can be considered.

Citing Articles

Reduction of thromboembolic events in meningioma surgery: a cohort study of 724 consecutive patients.

Valentin Eisenring C, Neidert M, Sabanes Bove D, Held L, Sarnthein J, Krayenbuhl N PLoS One. 2013; 8(11):e79170.

PMID: 24244441 PMC: 3828295. DOI: 10.1371/journal.pone.0079170.